KT&G Corporation (033780.KS)
Daejeon, KR
KT&G Corporation, a diversified South Korean enterprise that operates alongside its subsidiaries, specializes in a broad array of industries. Its primary business involves the manufacturing and distribution of tobacco products and related materials. Beyond this, the company is a significant provider of health and wellness items, offering red ginseng, various red ginseng-based goods, and other health-focused foods. Its extensive product portfolio also features food and beverage items, along with cosmetic and beauty products. Further diversifying its operations, KT&G offers support services for leaf tobacco cultivation and maintains a presence in the pharmaceutical and medical sectors. This includes the development, production, and supply of pharmaceuticals, encompassing bio-pharmaceuticals, over-the-counter medicines, and a range of medical supplies and equipment. The corporation also holds investments in commercial ventures such as trading, real estate management, property leasing, and housing development. Additionally, it is involved in the development and ongoing management of hotels. Founded in 1987, the company originally operated under the name Korea Tobacco and Ginseng Corporation before officially changing to KT&G Corporation in December 2002. Its corporate headquarters are situated in Daejeon, South Korea.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.00% | +3.82% | +10.83% | +5.75% | +29.15% | +29.70% | +56.85% | +115.25% | +120.46% | +45.10% | +727.73% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 6 | 0 |
| Buy | 13 | -1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Tobacco: +5.3%+11.4% ★ Q1'26: +14.3% (vs Q1'25)
-
EPS growth Tobacco: +18.8%-18.9% Q1'26: +40.0% (vs Q1'25)
-
FCF margin FCF growth · Tobacco: +9.5%+1.7% Q1'26: -13.6% (vs Q1'25)
-
EBIT margin Tobacco: +20.5%+20.4% Q1'26: +21.4% (vs Q1'25)
-
ROIC Tobacco: +16.0%+10.3% Q1'26: +11.0% (vs Q1'25)
-
Share dilution Tobacco: +0.0%+15.8% Q1'26: +5.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Tobacco: 0.25×1.13× Q1'26: 1.26× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 14 Rev. Ana. 16 EPS Ana. |
Dec 2027 19 Rev. Ana. 17 EPS Ana. |
Dec 2028 8 Rev. Ana. 10 EPS Ana. |
Dec 2029 10 Rev. Ana. 13 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.13T
est: 4.34T (-4.7%)
|
4.47T
est: 4.43T (+1.0%)
|
4.67T
est: 4.73T (-1.4%)
|
4.47T
est: 4.46T (+0.2%)
|
4.96T
est: 4.94T (+0.4%)
|
5.30T
est: 5.26T (+0.7%)
|
5.23T
est: 5.45T (-4.1%)
|
5.85T
est: 5.67T (+3.2%)
|
5.86T
est: 5.85T (+0.1%)
|
5.91T
est: 5.85T (+1.0%)
|
6.58T
est: 6.52T (+1.0%)
|
6.93T
6.83T – 7.13T
+6.3% YoY
|
7.28T
6.90T – 7.71T
+5.0% YoY
|
7.66T
7.40T – 7.99T
+5.2% YoY
|
7.51T
7.26T – 7.84T
-2.0% YoY
|
| EBITDA |
1.52T
est: 1.32T (+15.1%)
|
1.75T
est: 1.35T (+30.0%)
|
1.52T
est: 1.44T (+5.1%)
|
1.48T
est: 1.36T (+8.6%)
|
1.65T
est: 1.51T (+9.7%)
|
1.81T
est: 1.60T (+13.2%)
|
1.68T
est: 1.66T (+0.9%)
|
1.67T
est: 1.73T (-3.3%)
|
1.41T
est: 1.78T (-21.0%)
|
1.86T
est: 1.65T (+12.7%)
|
1.63T
est: 1.84T (-11.0%)
|
1.95T
1.93T – 2.01T
+6.3% YoY
|
2.05T
1.95T – 2.17T
+5.0% YoY
|
2.16T
2.09T – 2.25T
+5.2% YoY
|
2.12T
2.05T – 2.21T
-2.0% YoY
|
| EBIT |
1.44T
est: 1.15T (+25.5%)
|
1.59T
est: 1.17T (+36.3%)
|
1.35T
est: 1.25T (+8.3%)
|
1.33T
est: 1.18T (+12.4%)
|
1.47T
est: 1.31T (+12.4%)
|
1.61T
est: 1.39T (+15.8%)
|
1.46T
est: 1.44T (+1.3%)
|
1.45T
est: 1.50T (-3.6%)
|
1.17T
est: 1.55T (-24.6%)
|
1.61T
est: 1.41T (+14.4%)
|
1.34T
est: 1.57T (-14.3%)
|
1.67T
1.64T – 1.71T
+6.3% YoY
|
1.75T
1.66T – 1.85T
+5.0% YoY
|
1.84T
1.78T – 1.92T
+5.2% YoY
|
1.80T
1.74T – 1.88T
-2.0% YoY
|
| Net Income |
1.05T
est: 805.77B (+30.0%)
|
1.21T
est: 821.08B (+47.4%)
|
1.21T
est: 834.06B (+45.2%)
|
906.35B
est: 758.11B (+19.6%)
|
1.04T
est: 870.61B (+18.9%)
|
1.17T
est: 845.83B (+38.5%)
|
977.26B
est: 862.60B (+13.3%)
|
1.02T
est: 973.84B (+4.3%)
|
902.66B
est: 764.69B (+18.0%)
|
1.17T
est: 1.04T (+12.5%)
|
1.09T
est: 1.12T (-2.3%)
|
1.40T
1.25T – 1.62T
+25.0% YoY
|
1.53T
1.20T – 1.93T
+9.1% YoY
|
1.65T
1.58T – 1.74T
+7.9% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
572.56B
est: 731.91B (-21.8%)
|
631.27B
est: 746.89B (-15.5%)
|
711.04B
est: 798.48B (-11.0%)
|
734.45B
est: 752.98B (-2.5%)
|
779.32B
est: 833.82B (-6.5%)
|
805.01B
est: 888.24B (-9.4%)
|
779.61B
est: 920.39B (-15.3%)
|
874.04B
est: 957.24B (-8.7%)
|
849.53B
est: 987.93B (-14.0%)
|
852.85B
est: 833.68B (+2.3%)
|
822.87B
est: 929.13B (-11.4%)
|
988.07B
974.07B – 1.02T
+6.3% YoY
|
1.04T
984.22B – 1.10T
+5.0% YoY
|
1.09T
1.06T – 1.14T
+5.2% YoY
|
1.07T
1.03T – 1.12T
-2.0% YoY
|
| EPS |
8,314.00
est: 7,820.14 (+6.3%)
|
9,588.00
est: 7,968.69 (+20.3%)
|
9,591.00
est: 8,094.68 (+18.5%)
|
7,178.15
est: 7,357.61 (-2.4%)
|
8,207.82
est: 8,449.40 (-2.9%)
|
9,320.20
est: 8,208.95 (+13.5%)
|
7,898.24
est: 8,371.64 (-5.7%)
|
8,489.11
est: 9,451.26 (-10.2%)
|
7,843.00
est: 7,421.40 (+5.7%)
|
11,313.00
est: 8,682.97 (+30.3%)
|
9,170.03
est: 9,388.86 (-2.3%)
|
11,734.74
10,456.51 – 13,551.14
+25.0% YoY
|
12,799.82
10,084.33 – 16,156.16
+9.1% YoY
|
13,806.10
13,212.48 – 14,596.62
+7.9% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-15 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chang Gu Huh | Chief of Strategy & Planning | — | male |
| Gyeong-Bo Kang | Head of Finance | — | — |
| Hee-yeon Lee | IR director | — | — |
| Heung-Ryul Kim | Chief Vice President | — | male |
| Jae-Young Cho | Chief of Global Business | — | male |
| Jin-Han Kim | Chief Strategy Officer and Head of Strategy & Planning Office | — | male |
| Kwang-youl Lee | Senior Managing Director and Chief Technology Officer | — | male |
| Kyung-Man Bang | President, Chief Executive Officer & Representative Director | — | male |
| Min-Seok Kwon | Head of International Business | — | — |
| Sang-Hak Lee | Senior Executive Vice President, Chief Operating Officer and Director | — | male |
| Yong Beom Kim | Head of Finance Office | — | male |
| Young-Chan Yoon | Chief Marketing Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 033780.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
